The global bispecific and multispecific antibodies market is experiencing exponential growth, driven by growing demand for innovative therapies. These antibody formats offer significant therapeutic advantages by coordinatedly targeting two antigens, leading to enhanced efficacy and lowered side effects. Major players in the market are continuously